First electronic product information (ePI) published
![](https://unicom-project.eu/wp-content/uploads/2023/11/ePI-.png)
The Heads of Medicines Agencies (HMA), the European Commission (EC), the European Medicines Agency (EMA) and a number of pharma companies have published for the first time electronic product information (ePI) for selected human medicines harmonised across the […]
3rd GIDWG Stakeholder Group Meeting took place in Delft (Holland)
![](https://unicom-project.eu/wp-content/uploads/2023/04/The-PhPID-is-calculated-by-the-WHO-UMC-on-behalf-of-the-local-NCA.png)
UNICOM is engaged with the Global IDMP Working Group (GIDWG), created by EMA, FDA and WHO-UMC. The 3rd GIDWG Stakeholder Group Meeting took place this week and the results are […]
A PROMISING MPs substitution component!
![](https://unicom-project.eu/wp-content/uploads/2023/10/Patient-facing-app-UX.png)
Currently substitution in MyHealth@EU is limited to a “selection” of fully equivalent medicinal products. The potentialities of “substitution methodology”, proposed by UNICOM should be considered by the MyHealth@EU ePrescription Cluster […]
Join us in Ghent (Belgium) on November 29 – December 1
![](https://unicom-project.eu/wp-content/uploads/2023/10/DHDW-sticker-logos-1024x1024.png)
UNICOM has joint forces with two partner organisations (I~HD and EHTEL) to organise a very informative week in Ghent (Belgium) from November 29th till December 1st. We have two main objectives […]
Linking IDMP identifiers and ATC: What could be the benefits ?
![](https://unicom-project.eu/wp-content/uploads/2023/10/who-oslo.png)
On October 3, Dr Robert VanderStichele was representing UNICOM during a meeting organised by the WHO Collaborating Centre for Drug Statistics Methodology. He provided important insights on the opportunities for […]
Key messages from the fifth transatlantic meeting
![](https://unicom-project.eu/wp-content/uploads/2023/09/image-1024x432.png)
The fifth trans-Atlantic workshop orgnanised in february 2023 was attended by representatives from UNICOM, US and EU regulators, biopharmaceutical manufacturers and technology vendors. Meeting discussions focused on global IDMP Implementation […]